Daniel D. Shoemaker
2014
In 2014, Daniel D. Shoemaker earned a total compensation of $759K as Chief Scientific Officer at Fate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $48,510 |
|---|---|
| Option Awards | $433,568 |
| Salary | $265,000 |
| Stock Awards | $11,923 |
| Total | $759,001 |
Shoemaker received $433.6K in option awards, accounting for 57% of the total pay in 2014.
Shoemaker also received $48.5K in non-equity incentive plan, $265K in salary and $11.9K in stock awards.
Rankings
In 2014, Daniel D. Shoemaker's compensation ranked 8,737th out of 13,032 executives tracked by ExecPay. In other words, Shoemaker earned more than 33.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,737 out of 13,032 | 33rd |
Division Manufacturing | 3,246 out of 4,965 | 35th |
Major group Chemicals And Allied Products | 1,102 out of 1,690 | 35th |
Industry group Drugs | 877 out of 1,369 | 36th |
Industry Biological Products, Except Diagnostic Substances | 160 out of 241 | 34th |
Source: SEC filing on March 30, 2016.
Shoemaker's colleagues
We found three more compensation records of executives who worked with Daniel D. Shoemaker at Fate Therapeutics in 2014.